Incorporating ctDNA into clinical trial design
ctDNA offers immense possibilities for improving the management of early-stage lung cancer
ctDNA offers immense possibilities for improving the management of early-stage lung cancer
Simone Ledward-Boseman has many roles: She’s a writer, artist, and singer. And for some time, she was a caregiver to her late husband, Chadwick Boseman.
Investigators have found that the current body of research may inadequately address the intersection of aging, health disparities, and cancer outcomes among older patients.
The FDA has approved nogapendekin alfa inbakicept-pmln plus BCG for BCG-unresponsive non–muscle-invasive bladder cancer with carcinoma in situ with or without papillary tumors.
Monika Joshi, MD, MRCP, of Penn State Cancer Institute, contextualizes the results of the THOR study within the treatment landscape for FGFR2/3-altered advan…
This randomized clinical trial examines whether adding chemotherapy with pemetrexed and carboplatin to gefitinib improves survival among patients with epidermal growth factor receptor (EGFR)–variant non–small…
Your diet, including alcohol, can impact the body’s microbiome. Here, researcher Carrie Daniel-MacDougall, Ph.D., explains how alcohol affects the microbiome and the healthiest way to…
Establishing a nurse-led system to administer tocilizumab in patients receiving bispecific antibodies tended to get the immunosuppressive drug to patients faster.
SCIB1 plus nivolumab and ipilimumab elicited responses in patients with advanced, unresectable melanoma.
US cancer survivors are more likely than the general population to have a mobility or self-care disability, a large study suggests.
Douglas B. Johnson, MD, MSCI, of Vanderbilt-Ingram Cancer Center, discusses updated guidelines on the use of neoadjuvant therapy, as well as first- and later-line systemic…